MACULAR DEGENERATION; TYROSINE KINASE; IN-VITRO; VEGF-A; INHIBITOR; CANCER; BEVACIZUMAB; THERAPY; DISEASE; RETINA
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, v.30, no.10, pp.847 - 853
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.